Science Explorer Back to mapMap
Discussion
Researcher · Mitsubishi Group (Japan) · Japan

Reiko Tsuchiya

Reiko Tsuchiya publishes mostly in Molecular Biology, Oncology and Cellular and Molecular Neuroscience, on topics such as Molecular Biology Techniques and Applications, RNA modifications and cancer and Extracellular vesicles in disease.

OpenAlex
World rank
#2,343,294
of 7,710,434 ranked researchers
Rank in Japan
#45,992
of 383,136
Works
31
Citations
1.5k
Citations per work
48.3
h-index
12
i10-index 14Top 65% in Molecular Biology
Reiko Tsuchiya

What does Reiko Tsuchiya research?

Reiko Tsuchiya's work is mostly in Biochemistry, Genetics and Molecular Biology (41%), Neuroscience (6%), Medicine (6%).

Life Sciences: 16 works · 50.6% of their workBiochemistry, Genetics and Molecular Biology: 13 works · 40.7% of their workMolecular Biology: 10 works · 30.9% of their workCancer Research: 2 works · 4.9% of their workGenetics: 2 works · 4.9% of their workNeuroscience: 2 works · 6.2% of their workCellular and Molecular Neuroscience: 2 works · 6.2% of their workImmunology and Microbiology: 1 works · 3.7% of their workImmunology: 1 works · 3.7% of their workEverything else: 13 works · 43.2% of their workHealth Sciences: 2 works · 6.2% of their workMedicine: 2 works · 6.2% of their workOncology: 2 works · 6.2% of their workTHEIR WORKReiko Tsuchiya31works
Life Sciences51%Health Sciences6%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1340.7%
    2. Neuroscience26.2%
    3. Immunology and Microbiology13.7%
  2. Everything else1343.2%
    1. Medicine26.2%
  1. 1Molecular Biology31% of their works
  2. 2Oncology6% of their works
  3. 3Cellular and Molecular Neuroscience6% of their works
  4. 4Cancer Research5% of their works
  5. 5Genetics5% of their works
  6. 6Immunology4% of their works

Research topics

Which keywords describe Reiko Tsuchiya's research?

The keywords of their largest research topics: Cancer, Exosomes, Extracellular Vesicles, m6A-seq, Quantitative, Real-Time PCR, RNA methylation and Arginine Methylation.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Cancer52 topics
  2. Exosomes31 topic
  3. Extracellular Vesicles31 topic
  4. Quantitative31 topic
  5. RNA methylation31 topic
  6. Real-Time PCR31 topic
  7. m6A-seq31 topic
  8. Arginine Methylation21 topic
  9. Bacterial Therapy21 topic
  10. HIF-121 topic
  11. NK Cell Recognition21 topic
  12. Natural Killer Cells21 topic
  13. Protein Arginine Methyltransferases21 topic
  14. Sex Determination21 topic
  15. Tumor Targeting21 topic
  16. Warburg Effect21 topic
  17. X Chromosome Inactivation21 topic

Where does Reiko Tsuchiya work?

Reiko Tsuchiya's main affiliation in the publication record is Mitsubishi Group (Japan), Japan.

How many publications and citations does Reiko Tsuchiya have?

OpenAlex counts 31 works and 1,496 citations for Reiko Tsuchiya, an h-index of 12, ranking #2,343,294 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Reiko Tsuchiya. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.